Want to see ETST full AI Analyst Report?
Top Page
Earth Science Tech
(OTC:ETST)
Select Model
Select Model
Rating:54Neutral
Price Target:
$0.10
▼(-15.83% Downside)
Action:Reiterated
Date:07/31/26
The score is primarily constrained by financial volatility—especially the sharp TTM revenue collapse and operating losses—despite improved leverage and positive recent cash flow. Technicals also weigh on the rating because the stock trades well below major moving averages. Valuation is a relative positive due to the low P/E, and corporate updates on debt-free strategy and buybacks provide modest support, but not enough to overcome durability and trend concerns.
Positive Factors
Balance Sheet Strength
The company reports conservatively low leverage and expanded equity vs earlier years, improving financial resilience. Durable low debt increases flexibility for capex, M&A, or buybacks, and reduces refinancing risk during downturns, supporting multi-quarter stability.
Negative Factors
Revenue Volatility
A pronounced TTM revenue collapse materially weakens confidence in sustainable top-line performance. Persistent or recurring revenue swings undermine margin stability, hinder forecasting, and limit the company's ability to plan durable investments or scale operations reliably.
Read all positive and negative factors
Positive Factors
Negative Factors
Balance Sheet Strength
The company reports conservatively low leverage and expanded equity vs earlier years, improving financial resilience. Durable low debt increases flexibility for capex, M&A, or buybacks, and reduces refinancing risk during downturns, supporting multi-quarter stability.
Read all positive factors
Earth Science Tech (ETST) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$31.61M
Dividend YieldN/A
Average Volume (3M)44.92K
Price to Earnings (P/E)8.9
Beta (1Y)2.73
Revenue Growth7.78%
EPS Growth15.89%
CountryUS
Employees77
SectorHealthcare
Sector Strength45
IndustryDrug Manufacturers - Specialty & Generic
Share Statistics
EPS (TTM)0.01
Shares Outstanding287,590,880
10 Day Avg. Volume74,750
30 Day Avg. Volume44,925
Financial Highlights & Ratios
PEG Ratio0.45
Price to Book (P/B)3.71
Price to Sales (P/S)0.73
P/FCF Ratio21.98
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.03
Revenue Forecast (FY)$43.22M
Earth Science Tech Business Overview & Revenue Model
Company Description
Earth Science Tech, Inc. (EST) is a biotechnology firm dedicated to the worldwide development and distribution of nutraceuticals, bioceuticals, and dietary supplements. These offerings aim to support general health, overall well-being, nutrition, ...
How the Company Makes Money
null...
Earth Science Tech Financial Statement Overview
Summary
Income Statement
44
Neutral
Balance Sheet
68
Positive
Cash Flow
62
Positive
| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Jun 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 35.70M | 33.12M | 11.95M | 48.54K | 14.12K |
| Gross Profit | 25.49M | 24.30M | 7.83M | 22.06K | -8.52K |
| EBITDA | 3.39M | 3.54M | 1.04M | -300.48K | -219.21K |
| Net Income | 3.63M | 3.25M | 812.14K | -365.40K | 3.17M |
Balance Sheet | |||||
| Total Assets | 8.97M | 7.07M | 3.88M | 2.69M | 76.94K |
| Cash, Cash Equivalents and Short-Term Investments | 2.16M | 2.12M | 697.72K | 35.76K | 26.94K |
| Total Debt | 96.21K | 401.24K | 246.59K | 974.11K | 780.69K |
| Total Liabilities | 1.93M | 3.22M | 1.63M | 1.61M | 1.88M |
| Stockholders Equity | 7.01M | 3.85M | 2.25M | 1.08M | -1.81M |
Cash Flow | |||||
| Free Cash Flow | 1.18M | 3.62M | 1.18M | -1.01M | -166.39K |
| Operating Cash Flow | 1.94M | 4.37M | 1.21M | -1.01M | -168.11K |
| Investing Cash Flow | -1.90M | -1.88M | -26.52K | 0.00 | 1.71K |
| Financing Cash Flow | -712.92K | -1.72M | -517.88K | 1.02M | 173.18K |
Earth Science Tech Technical Analysis
Negative
0.12
Price Trends
0.16
Negative
0.14
Negative
0.14
Negative
Market Momentum
-0.02
Positive
33.50
Neutral
13.58
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For ETST, the sentiment is Negative. The current price of 0.12 is below the 20-day moving average (MA) of 0.13, below the 50-day MA of 0.16, and below the 200-day MA of 0.14, indicating a bearish trend. The MACD of -0.02 indicates Positive momentum. The RSI at 33.50 is Neutral, neither overbought nor oversold. The STOCH value of 13.58 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for ETST.
Earth Science Tech Risk Analysis
Earth Science Tech disclosed 38 risk factors in its most recent earnings report. Earth Science Tech reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Earth Science Tech Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
59 Neutral | $100.09M | -13.51 | -28.75% | ― | 2.08% | -106.57% | |
54 Neutral | $31.61M | 8.93 | 71.39% | ― | 7.78% | 15.89% | |
54 Neutral | $28.38M | -4.84 | -15.41% | ― | -30.75% | -1059.59% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
49 Neutral | $66.43M | -3.56 | -92.98% | ― | -96.30% | 32.21% | |
48 Neutral | $48.06M | -1.35 | -57.16% | ― | 673.54% | 23.14% | |
44 Neutral | $13.38M | -0.33 | -96.48% | ― | 29.75% | 37.35% |
* Healthcare Sector Average
ETST
Earth Science Tech
0.09
-0.09
-48.89%
TLPH
Talphera
1.36
0.97
246.06%
RMTI
Rockwell Med
7.57
-2.43
-24.29%
SCYX
SCYNEXIS
5.40
-0.27
-4.80%
CPIX
Cumberland Pharmaceuticals
7.77
4.83
164.47%
COSM
Cosmos Holdings
0.22
-0.65
-74.49%
Earth Science Tech Corporate Events
Business Operations and StrategyStock BuybackFinancial DisclosuresRegulatory Filings and Compliance
Earth Science Tech Highlights Transformational Debt-Free Growth Strategy
Positive
Jun 10, 2026
Earth Science Tech, Inc., a Miami-based strategic holding company in the health and wellness space, reported that the fiscal year ended March 31, 2026, was transformational as it advanced a vertically integrated healthcare model spanning telemedic...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.